ABVC BioPharma, Inc. Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest
ABVC BioPharma, Inc. (ABVC) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest of -$92.17 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity · last filed 2022-05-16
- ABVC BioPharma, Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2022-03-31 was -$92.17K.
- ABVC BioPharma, Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2021-12-31 was $1.03M.
- ABVC BioPharma, Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2021-09-30 was -$79.76K.
- ABVC BioPharma, Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2021-06-30 was -$81.39K.
- ABVC BioPharma, Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2021 was $802.96K.
- ABVC BioPharma, Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2020 was -$802.42K.
- ABVC BioPharma, Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2019 was -$291.46K.
- ABVC BioPharma, Inc. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2018 was -$489.15K.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$92.17K 10-Q · filed 2022-05-16 | $938.75K derived: sum of 2 quarters · filed 2022-05-16 | $859.00K derived: sum of 3 quarters · filed 2022-05-16 | $777.61K derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $951.17K derived: sum of 2 quarters · filed 2022-03-31 | $869.78K derived: sum of 3 quarters · filed 2022-03-31 | $802.96K 10-K · filed 2022-03-31 |
| 2021-09-30 | -$79.76K 10-Q · filed 2021-11-15 | -$161.15K derived: sum of 2 quarters · filed 2021-11-15 | -$227.96K 10-Q · filed 2021-11-15 | -$348.81K derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-06-30 | -$81.39K 10-Q · filed 2021-08-12 | -$148.21K 10-Q · filed 2021-08-12 | -$269.06K derived: sum of 3 quarters · filed 2022-05-16 | -$554.14K derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-03-31 | -$66.82K 10-Q · filed 2022-05-16 | -$187.67K derived: sum of 2 quarters · filed 2022-05-16 | -$472.75K derived: sum of 3 quarters · filed 2022-05-16 | -$807.51K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$120.85K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$405.94K derived: sum of 2 quarters · filed 2022-03-31 | -$740.70K derived: sum of 3 quarters · filed 2022-03-31 | -$802.42K 10-K · filed 2022-03-31 |
| 2020-09-30 | -$285.08K 10-Q · filed 2021-11-15 | -$619.85K derived: sum of 2 quarters · filed 2021-11-15 | -$681.57K 10-Q · filed 2021-11-15 | -$719.68K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$334.76K 10-Q · filed 2021-08-12 | -$396.48K 10-Q · filed 2021-08-12 | -$434.60K derived: sum of 3 quarters · filed 2021-08-12 | -$549.42K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$61.72K 10-Q · filed 2021-05-10 | -$99.84K derived: sum of 2 quarters · filed 2021-05-10 | -$214.66K derived: sum of 3 quarters · filed 2021-05-10 | -$271.54K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | -$38.12K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$152.94K derived: sum of 2 quarters · filed 2021-03-16 | -$209.82K derived: sum of 3 quarters · filed 2021-03-16 | -$291.46K 10-K · filed 2021-03-16 |
| 2019-09-30 | -$114.83K 10-Q · filed 2020-11-17 | -$171.70K derived: sum of 2 quarters · filed 2020-11-17 | -$253.35K 10-Q · filed 2020-11-17 | -$409.90K derived: sum of 4 quarters · filed 2020-11-17 |
| 2019-06-30 | -$56.88K 10-Q · filed 2020-08-14 | -$138.52K 10-Q · filed 2020-08-14 | -$295.08K derived: sum of 3 quarters · filed 2020-08-14 | -$411.57K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | -$81.65K 10-Q · filed 2020-06-29 | -$238.20K derived: sum of 2 quarters · filed 2020-06-29 | -$354.69K derived: sum of 3 quarters · filed 2020-06-29 | -$458.56K derived: sum of 4 quarters · filed 2020-06-29 |
| 2018-12-31 | -$156.56K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-15 | -$273.05K derived: sum of 2 quarters · filed 2020-05-15 | -$376.92K derived: sum of 3 quarters · filed 2020-05-15 | -$489.15K 10-K · filed 2020-05-15 |
| 2018-09-30 | -$116.49K 10-Q · filed 2019-11-18 | -$220.36K derived: sum of 2 quarters · filed 2019-11-18 | -$332.60K 10-Q · filed 2019-11-18 | |
| 2018-06-30 | -$103.87K 10-Q · filed 2019-08-09 | -$216.10K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | -$112.23K 10-Q · filed 2019-05-28 |